Clinical trial
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related…
NCT00032149 · Lymphoma Trials Office, Other · Unknown status
Key facts
| NCT number | NCT00032149 |
|---|---|
| Title | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma |
| Official title | Pilot Study Of PMitCEBO Plus G-CSF In Good-Prognosis HIV-Related Lymphoma |
| Lead sponsor | Lymphoma Trials Office, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, filgrastim, cyclophosphamide, etoposide, mitoxantrone hydrochloride, prednisolone, vincristine sulfate |
| Enrollment | 30 |
| Start date | Oct 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: